-+ 0.00%
-+ 0.00%
-+ 0.00%

Capstone Holding posts investor presentation after filing Q2 10-Q

PUBT·08/12/2026 11:39:42
Listen to the news
Capstone Holding posts investor presentation after filing Q2 10-Q
  • Capstone Therapeutics Corporation posted an investor presentation following its Q2 2026 Form 10-Q filing.
  • Q2 revenue rose 67% to $21.5 million; gross profit increased 92% to $6 million; gross margin expanded to 27.9%.
  • Stone Business Adjusted EBITDA was $2 million, a 9.4% margin; GAAP net loss widened to $1.4 million.
  • FY2026 guidance reaffirmed: $72.1 million revenue; $18.7 million gross profit; about $3.8 million Stone Business Adjusted EBITDA.
  • Materials available in Investor Relations at https://www.capstoneholdingcorp.com.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capstone Therapeutics Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260812438778) on August 12, 2026, and is solely responsible for the information contained therein.